201 related articles for article (PubMed ID: 22811704)
1. Pathogenic and Diagnostic Potential of BLCA-1 and BLCA-4 Nuclear Proteins in Urothelial Cell Carcinoma of Human Bladder.
Santoni M; Catanzariti F; Minardi D; Burattini L; Nabissi M; Muzzonigro G; Cascinu S; Santoni G
Adv Urol; 2012; 2012():397412. PubMed ID: 22811704
[TBL] [Abstract][Full Text] [Related]
2. The role of the BLCA-4 nuclear matrix protein in bladder cancer.
Szymańska B; Długosz A
Postepy Hig Med Dosw (Online); 2017 Aug; 71(1):681-689. PubMed ID: 28894042
[TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer.
Konety BR; Nguyen TS; Brenes G; Sholder A; Lewis N; Bastacky S; Potter DM; Getzenberg RH
J Urol; 2000 Sep; 164(3 Pt 1):634-9. PubMed ID: 10953114
[TBL] [Abstract][Full Text] [Related]
4. BLCA-4 expression is related to MMP-9, VEGF, IL-1α and IL-8 in bladder cancer but not to PEDF, TNF-α or angiogenesis.
Feng C; Wu Z; Guo T; Jiang H; Guan M; Zhang Y; Wen H; Ding Q
Pathol Biol (Paris); 2012 Jun; 60(3):e36-40. PubMed ID: 22197408
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic analysis of the role of BLCA-4 in bladder cancer pathobiology.
Myers-Irvin JM; Van Le TS; Getzenberg RH
Cancer Res; 2005 Aug; 65(16):7145-50. PubMed ID: 16103064
[TBL] [Abstract][Full Text] [Related]
6. Deregulated Expression of
Papasavva M; Amvrosiou S; Pilala KM; Soureas K; Christodoulou P; Ji Y; Stravodimos K; Xu D; Scorilas A; Avgeris M; Christodoulou MI
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298214
[TBL] [Abstract][Full Text] [Related]
7. Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4.
Konety BR; Nguyen TS; Dhir R; Day RS; Becich MJ; Stadler WM; Getzenberg RH
Clin Cancer Res; 2000 Jul; 6(7):2618-25. PubMed ID: 10914702
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of the bladder cancer marker, BLCA-4.
Van Le TS; Myers J; Konety BR; Barder T; Getzenberg RH
Clin Cancer Res; 2004 Feb; 10(4):1384-91. PubMed ID: 14977841
[TBL] [Abstract][Full Text] [Related]
9. An RNA-sequencing-based transcriptome for a significantly prognostic novel driver signature identification in bladder urothelial carcinoma.
Liu D; Zhou B; Liu R
PeerJ; 2020; 8():e9422. PubMed ID: 32742772
[TBL] [Abstract][Full Text] [Related]
10. [Urinary BLCA-4 level is useful to detect upper urinary tract urothelial cell carcinoma].
Feng CC; Wu Z; Jiang HW; Wen H; Guan M; Ding Q
Actas Urol Esp; 2012; 36(10):597-602. PubMed ID: 22998857
[TBL] [Abstract][Full Text] [Related]
11. BLCA-4 and UBC combined detection for early diagnosis of bladder cancer.
Cui L; Sun MM; Zhao ZH; Yang JP; Zheng YP; He LL; Chen KS; Fan QX
J Biol Regul Homeost Agents; 2016; 30(2):485-90. PubMed ID: 27358136
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of CXCL12 expression reveals the significance of inflammatory fibroblasts in bladder cancer carcinogenesis and progression.
Du Y; Cao J; Jiang X; Cai X; Wang B; Wang Y; Wang X; Xue B
Cancer Cell Int; 2021 Nov; 21(1):613. PubMed ID: 34801033
[TBL] [Abstract][Full Text] [Related]
13. Integration of the cancer cell secretome and transcriptome reveals potential noninvasive diagnostic markers for bladder cancer.
Chen YT; Tu WJ; Ye ZH; Wu CC; Ueng SH; Yu KJ; Chen CL; Peng PH; Yu JS; Chang YH
Proteomics Clin Appl; 2024 Jan; ():e2300033. PubMed ID: 38196148
[TBL] [Abstract][Full Text] [Related]
14. Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer.
Herman MP; Svatek RS; Lotan Y; Karakiewizc PI; Shariat SF
Minerva Urol Nefrol; 2008 Dec; 60(4):217-35. PubMed ID: 18923359
[TBL] [Abstract][Full Text] [Related]
15. Screening and Identification of Key Biomarkers for Bladder Cancer: A Study Based on TCGA and GEO Data.
Xu Y; Wu G; Li J; Li J; Ruan N; Ma L; Han X; Wei Y; Li L; Zhang H; Chen Y; Xia Q
Biomed Res Int; 2020; 2020():8283401. PubMed ID: 32047816
[TBL] [Abstract][Full Text] [Related]
16. FUT7 Promotes the Epithelial-Mesenchymal Transition and Immune Infiltration in Bladder Urothelial Carcinoma.
Liu M; Zheng Q; Chen S; Liu J; Li S
J Inflamm Res; 2021; 14():1069-1084. PubMed ID: 33790621
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
[TBL] [Abstract][Full Text] [Related]
18. RNA-Sequencing Data Reveal a Prognostic Four-lncRNA-Based Risk Score for Bladder Urothelial Carcinoma: An in Silico Update.
He RQ; Huang ZG; Li TY; Wei YP; Chen G; Lin XG; Wang QY
Cell Physiol Biochem; 2018; 50(4):1474-1495. PubMed ID: 30359990
[TBL] [Abstract][Full Text] [Related]
19. PLAUR as a Potential Biomarker Associated with Immune Infiltration in Bladder Urothelial Carcinoma.
Liu M; Chen S; Zhang A; Zheng Q; Fu J
J Inflamm Res; 2021; 14():4629-4641. PubMed ID: 34552345
[TBL] [Abstract][Full Text] [Related]
20. LncRNA TMPO-AS1 promotes proliferation and migration in bladder cancer.
He YC; Bi YG; Jiang L
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8740-8746. PubMed ID: 32964962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
